The metabolic regulation of CD147 occurs through its direct or indirect interaction with specific protein partners related to glycolysis, OXPHOS, hypoxia, and lipolysis, which are dysregulated metabolic pathways in cancer, including hematologic malignancies [80,81]. This evidence concerns the gene BSG and hematologic disorder.